Pharmafile Logo

Patient Recruitment & Retention Strategies in the 2024 Clinical Trial Landscape

- PMLiVE

In the landscape of the clinical trial industry in 2024, persistent challenges persist in the realms of patient recruitment and retention. These hurdles, having endured over several years, continue to pose significant obstacles. As we navigate through the complexities of the current year, experts in the field—namely, Kate Shaw, Leanne Whoehlke, and Will Krugman—will delve into pivotal aspects of patient recruitment and retention challenges. The discussion will intricately explore strategies to augment awareness of clinical trials within the broader public sphere, contemplating innovative approaches to engage with local communities. The focus remains steadfast on ensuring that patient recruitment and retention remain robust throughout the clinical trials course. This discourse promises to illuminate and address critical issues, propelling the clinical trial industry toward enhanced efficacy and patient-centred success.

This content was provided by Innovative Trials

Company Details

 Latest Content from  Innovative Trials 

Seven strategic steps to enhance patient recruitment & retention in your influenza studies

The development of all treatments, including vaccines, is dependent on people taking part in clinical trials but this can be challenging for influenza studies, especially given the typically short patient...

Innovative Trials celebrates success for its groundbreaking Retention Patch Program

Innovative Trials attended the PME Award Gala Dinner last night (21st November 2024)

Movember 2024 – Men’s Health

This Movember, Innovative Trials are raising awareness about men’s health issues like prostate cancer, testicular cancer, and mental health.

Is your influenza clinical trial prepared for the upcoming flu season? Part 3

This blog will discuss some important aspects to consider to maximise patient retention on your flu clinical trials. For more information on patient recruitment considerations, check out our previous blogs...

Is your influenza clinical trial prepared for the upcoming flu season? Part 2

Around 86% of clinical trials do not meet patient recruitment goals, ultimately failing to improve patient outcomes and resulting in financial losses for sponsors and research sites (Rangu and Maxwell,...

Is your influenza clinical trial prepared for the upcoming flu season? Part 1

The Northern Hemisphere flu season is fast approaching, bringing with it a multitude of challenges for respiratory clinical trials. The exact dates of the flu season in the Northern Hemisphere...

How Innovative Trials are making a difference to clinical trials in the US

Eloise Moffett, Innovative Trials’ Vice President of Commercial, reflects on how the company’s growing presence in the US is transforming client relationships and its ability to provide the best patient-centric...

Innovative Trials named a top UK women-powered company in clinical research by J.P. Morgan

Innovative Trials has been named the second-fastest-growing, women-powered UK company in clinical research and ranks among the top 200 women-powered businesses in the UK!

Innovative Trials named a finalist at the PME Award

Patient recruitment and retention company, Innovative Trials, was shortlisted as a finalist in the PME Award for its collaboration with US non-profit Oliver Patch Project to improve patient outcomes.

Innovative Trials appoints new Leadership Team member

Patient Recruitment company, Innovative Trials, appointed new Finance and Business Services Director